SUBSCRIBE
SUBSCRIBE
News   Drug Development

Momenta Pharmaceuticals, Inc. (Jobs) Sees Longer US Review for Generic Lovenox

June 28, 2007 | 
1 min read
NEW YORK, June 28 (Reuters) - Momenta Pharmaceuticals Inc. said on Thursday a U.S. review of its application to sell a generic version of Sanofi-Aventis' big-selling Lovenox blood-thinner is taking longer than it previously projected.
Clinical research Postmarket research
MORE ON THIS TOPIC
Business and financial crisis vector concept with businessman falling down the hole. Symbol of market crash, recession, risk, bankruptcy and loss. Eps10 illustration.
Neuropsychiatric disorders
Vistagen in freefall as social anxiety drug fails Phase 3
July 1, 2026
 · 
2 min read
 · 
Tristan Manalac
Podcast
Sentiment at BIO soars as FDA resets, dealmaking evolves; Amgen’s Tavneos in hot water
July 1, 2026
 · 
2 min read
 · 
Jef Akst
A man and woman on opposite edges of a large chat bubble
Insights
Golden Triangle still dominates, but talent and capital gaps slow biotech growth
July 1, 2026
 · 
3 min read
 · 
Jennifer C. Smith-Parker
Halftone collage of two hands that untangles tangled ball or messy line. Concept of solving mental problems or simplification of a complex process in business. Vector illustration.
Job Trends
Opinion: Innovation wins the contract. Complexity loses the renewal
July 1, 2026
 · 
3 min read
 · 
Antonio Serrano